a School of Pharmaceutical Sciences , Hubei University of Medicine , Shiyan , Hubei , China.
b Division of Life Science, Key Lab in Healthy Science and Technology , Graduate School at Shenzhen, Tsinghua University , Shenzhen , China.
Drug Deliv. 2019 Dec;26(1):168-178. doi: 10.1080/10717544.2019.1568622.
The present study aims at designing a thermosensitive gel prepared from w1/o/w2 multiple microemulsions (MMEs) for the vaginal delivery of siRNA. The w1/o/w2 MMEs were prepared by two-step emulsifications: the first step was to prepare primary emulsions (w1/o) by low energy emulsification (LEE); the second step was to obtain stable w1/o/w2 MMEs by self-emulsifying. An extensive formulation optimization process was undertaken. The final w1/o/w2 MMEs could be formed in ddHO, phosphate buffer solution (PBS, pH 7.4) and 1640 culture media with diameter size about 166.5 ± 13.1, 271.0 ± 11.1 and 278.7 ± 12.1 nm respectively. The release rates of siRNA from solutions, MMEs and MMEs-gels were completed within 2 h, 6 h and13 h respectively. The transfection efficiency of MMEs was confirmed both in vitro and in vivo. The relative target gene expressions of MMEs were 0.07 ± 0.05% vs. 0.37 ± 0.06% in Hela cells against Lipofectamine2000® and 1.88% ± 0.00% vs. 9.65% ± 0.02% in mouse vaginal mucosa against PEI. Good biocompatibility of MMEs was verified by cytotoxicity and pathological studies. Overall, our results indicated the potential of the MMEs-gel system for the vaginal delivery of siRNA.
本研究旨在设计一种由 w1/o/w2 多重微乳液(MME)制成的温敏凝胶,用于阴道递送 siRNA。w1/o/w2 MME 通过两步乳化法制备:第一步通过低能量乳化(LEE)制备初级乳液(w1/o);第二步通过自乳化获得稳定的 w1/o/w2 MME。进行了广泛的配方优化过程。最终的 w1/o/w2 MME 可以在 ddHO、磷酸盐缓冲液(PBS,pH7.4)和 1640 培养基中形成,其直径分别约为 166.5±13.1nm、271.0±11.1nm 和 278.7±12.1nm。siRNA 从溶液、MME 和 MME 凝胶中的释放速率分别在 2h、6h 和 13h 内完成。在体外和体内均证实了 MME 的转染效率。MME 的相对靶基因表达在 Hela 细胞中分别为 0.07±0.05%比对照 Lipofectamine2000®的 0.37±0.06%,在小鼠阴道黏膜中分别为 1.88%±0.00%比对照 PEI 的 9.65%±0.02%。通过细胞毒性和病理研究验证了 MME 的良好生物相容性。总体而言,我们的结果表明 MME 凝胶系统在阴道递送 siRNA 方面具有潜力。